SurpassMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.5/10
Best for: a published price for every supply term, with no price rise as the dose climbs
SurpassMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $143 a month, 28% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
SurpassMD, a brand of Life Vitality LLC, connects cash-pay patients with an independent medical group for compounded semaglutide, tirzepatide and oral semaglutide. Price depends on supply term, not dose: semaglutide is $219 a month on a 30-day plan and $143 on a 12-month term; tirzepatide is $309 and $222. Advertised $114 and $177 prices are first-subscription discounts. Service is claimed in every state plus DC.
Is SurpassMD legit?
Yes. SurpassMD is a real, operating US company, and we found no FDA warning letters issued to it. It says its medication comes from accredited compounding pharmacies (503A, 503B or PCAB). We rate it 8.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a SurpassMD promo or coupon code?
We know of no promo or coupon code for SurpassMD. Its listed price is $143 a month. Coupon sites advertising "SurpassMD discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how SurpassMD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to SurpassMD
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
SurpassMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $143/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Consult · Medication · Shipping
- Availability
- All 50 states + DC
- FDA status
- No FDA warning letters found
How SurpassMD scores
Six columns, each one computed from something SurpassMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.4/10$143/month is 28% below the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
8.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states and DC.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on SurpassMD
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for SurpassMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with SurpassMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1SurpassMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask SurpassMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $143, tirzepatide $222. That leaves out membership fees, first-month rates and insurance copays.
- SurpassMD serves all 50 states and DC.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting SurpassMD
- Phone
- 1-502-515-4576
- SurpassMD offers email support
- Hours
- Monday-Friday, 9 AM-6 PM PT
Cancelling SurpassMD
Taken from the terms SurpassMD publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None stated in the Terms of Use; the separate Refund Policy page requires 72 hours' notice before your next billing date
- Refund policy
- Conflicting: Terms of Use Section 12 says refunds are available any time unless that period's medication already shipped; the separate Cancellation and Refund Policy page says no refunds are issued upon cancellation except when disqualified by the medical provider
- Early-termination fee
- None
Medications SurpassMD lists
SurpassMD lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
"30-day supply ... Standard renewal rate: $219 Introductory price: $175" (intro needs a discount code, first subscription only). 3-month $195, 6-month $180 per month.
"12-month supply ... Standard renewal rate: $143 Introductory price: $114" (intro needs a discount code, first subscription only). Billing schedule for the 12-month term is not stated on the page.
"30-day supply ... Standard renewal rate: $309 Introductory price: $247" (intro needs a discount code, first subscription only). 3-month $299, 6-month $275 per month.
"12-month supply ... Standard renewal rate: $222 Introductory price: $177" (intro needs a discount code, first subscription only). Billing schedule for the 12-month term is not stated on the page.
Check the price yourself before you pay
Every figure here comes from SurpassMD's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $143 a month, 28% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $222 a month, 17% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states and DC
- We found no FDA warning letters issued to SurpassMD
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What SurpassMD charges
SurpassMD lists $143/month, flat regardless of dose. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide (30-day supply): $219/month
- Compounded semaglutide (12-month supply): $143/month
- Compounded tirzepatide (30-day supply): $309/month
- Compounded tirzepatide (12-month supply): $222/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so SurpassMD's $143 is genuinely below the middle, not just advertised that way. Before you pay, compare SurpassMD's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Ivim Health dispenses semaglutide and tirzepatide from $140/month, which makes it the fair comparison to run before you commit here.
What SurpassMD dispenses
SurpassMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
SurpassMD tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and that its pharmacy is accredited. We found no FDA warning letters issued to SurpassMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If SurpassMD will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether SurpassMD bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access wherever you live
Our read
SurpassMD competes on price without an obvious sacrifice elsewhere: $143/month, no FDA warning letters, and wide state coverage.
The Bottom Line
SurpassMD scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care. Its compounded semaglutide costs $143 a month, 28% below the $199 median among the sellers we compare.
Before you pay SurpassMD
Starting at $143 a month. Check today's price, then start the intake.
Where SurpassMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider RxSpan MD.
If none of these fits, our guide to alternatives to SurpassMD sets more sellers in the same category beside SurpassMD on price, states and what the price includes.
Frequently Asked Questions
How to check SurpassMD yourself
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Arizona, Georgia, Idaho, Maine, Maryland, Mississippi, New Hampshire, Oklahoma and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this SurpassMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See SurpassMD's current pricing
Plans start at $143 a month. Whether you qualify is a clinician's decision, made after your intake.